Physiologically based pharmacokinetic model for CAR-T cell delivery and efficacy in solid tumors
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Proceedings of the National Academy of Sciences, Volume 122, Number 46, November 2025.
ImportancePreclinical studies and early clinical trials of chimeric antigen receptor (CAR)-T therapy show encouraging responses in glioblastoma, diffuse midline gliomas, and neuroblastoma, but substantial obstacles remain for effective CAR-T therapy in…
